Clinical Study
Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
Table 1
Baseline patients characteristics.
| | Variable | |
| | Number of patients | 30 | | Sex (M/F) | 23/7 | | Median age at listing years (range) | 55 (35–68) | | Origin (%) | | | Caucasian | 22 (73) | | Asian | 4 (13) | | South American | 3 (10) | | African | 1 (3) | | Cause of liver cirrhosis (%) | | | Hepatitis C virus | 9 (33) | | Hepatitis B virus | 8 (27) | | Combined causes | 9 (30) | | Alcohol abuse | 2 (7) | | NASH | 2 (7) | | Hepatocellular carcinoma (%) | 30 (100) | | Diagnosis (%) | | | 2 imaging studies | 18 (60) | | 1 imaging study + alfa-foeto proteins | 9 (30) | | Biopsy | 3 (10) | | Median AFP, ng/ml (range) | 27,8 (2.6–3000) | | Mean lesion size, mm (range) | 23,8 (10–60 mm) | | Number of lesions, patients (%) | | | One lesion | 18 (60) | | Two lesions | 3 (10) | | Three lesions | 7 (23) | | Four lesions | 2 (7) | | Milan at diagnosis (%) | | | In | 24 (80) | | Out | 6 (20) |
|
|